Klijn, Sven L. http://orcid.org/0000-0002-1556-8382
Hiligsmann, Mickaël
Evers, Silvia M. A. A.
Román-Rodríguez, Miguel
van der Molen, Thys
van Boven, Job F. M.
Article History
Received: 5 October 2016
Revised: 2 February 2017
Accepted: 14 February 2017
First Online: 13 April 2017
Competing interests
: Mr. S.K. reports current employment (Pharmerit International), during the study he was a student at Maastricht University. Dr. M.R.R. reports personal fees from Astra Zeneca, personal fees from Boehringer Ingelheim, grants and personal fees from GSK, personal fees from Mundipharma, personal fees from Novartis, personal fees from TEVA, outside the submitted work. Dr. T.v.d.M. reports grants and personal fees from Glaxo, grants and personal fees from Astra Zeneca, personal fees and non-financial support from Teva, personal fees from Mundifarma, personal fees from Boehringer Ingelheim, outside the submitted work. Dr. J.F.M.v.B. reports grants (GSK, Boehringer Ingelheim), consultancy fees (AstraZeneca) and travel fees (European COPD Coalition, Respiratory Effectiveness Group) outside the submitted work. Other authors report no disclosures.